Clinical Oncology 2023 Peer Review Trainees Chosen

Friday 26 May 2023

The RCR and the Clinical Oncology editorial board are delighted to announce the following successfully applicants for the Clinical Oncology peer review training programme.

Clinical Oncology has developed a peer-review training programme that will enable these oncology trainees, under the supervision of the journal editors, to enhance their skills in reviewing and writing scientific papers.  

The programme offers trainees not only the chance to develop their academic writing and critical analysis skills. It also allows you the chance to help guest edit special issues of Clinical Oncology, develop new journal content, participate in editorial board meetings and participate in a journal publication workshop (September 2023). 

Clinical Oncology peer review trainees:

  • Dr Amani Chowdhury – Current ST7 trainee, taking time out of programme to pursue a brachytherapy fellowship at Mount Vernon Cancer Centre, as well as an MD (Res) degree focusing on strategies to optimise delivery of radiotherapy in gynaecological malignancies.
  • Dr Andrada Turcas – A radiation oncology resident at the Oncology Institute in Cluj-Napoca, Romania, and a PhD candidate at the University of Medicine and Pharmacy, Cluj-Napoca.
  • Dr Benjamin Pickwell-Smith – A medical oncology specialist registrar in West Yorkshire, currently completing a PhD at Hull York Medical School focusing on the evaluation of socioeconomic inequalities in cancer diagnosis and treatment.
  • Dr C. Will Bleaney – An NIHR academic clinical fellow and speiality registrar in clinical oncology at The Christie Hospital, Manchester.
  • Dr Dana Shor – An ST7 clinical oncology specialist registrar in the East of England, and nearing completion of a Clinical Fellowship in radiation oncology in Toronto, Canada, specialising in CNS and lung malignancies.
  • Dr Daniel Hughes – A medical oncology trainee at University College London, currently completing an MSc in medical education and lecturing at the UCL Medical School.
  • Dr Emily Renninson – An ST7 SpR in Bristol, Severn Deanery, having just passed her final FRCR exam.
  • Dr Farasat Kazmi – An ST5 clinical oncology trainee in the East of England, having obtained an MSc in Nanomedicine.
  • Dr Francesca Holt – Currently working with the ‘Benefits and Risks of Cancer Treatments' team at Oxford Population Health on projects aiming to estimate the benefits and risks of different types of adjuvant radiotherapy for early breast cancer, funded by an NIHR fellowship.
  • Dr Jill Nicholson – Currently in her final year of training in radiation oncology and her research fellowship at St Luke’s Institute of Cancer Research and Trinity College, Dublin, which focuses on optimizing breast cancer radiotherapy and incorporating artificial intelligence into treatment pathways. Jill is also pursuing a Master’s in medical education (Oncology) at the University of Dundee.
  • Dr Joon Wee Ho – Focuses on CNS tumours, including brain tumours, meningioma and brain metastases, as well as breast cancer. Joon regularly teaches medical students, doctors and junior registrars.
  • Dr Mary Denholm – A clinical oncology trainee in the East of England, holding a Cancer Research UK research training fellowship and undertaking a PhD at the University of Cambridge to examine the role of therapy-induced cellular senescence in non-small cell lung cancer.
  • Dr Shefali Parikh – An ST5 clinical oncology trainee in the West Midlands, with both an OOPE as a leadership fellow and a PGDip in clinical education.